Came across, metastatic; mOS, average full survival; No Rec, zero recurrence; NR, perhaps not achieved; Rec, recurrence
Came across, metastatic; mOS, average full survival; No Rec, zero recurrence; NR, perhaps not achieved; Rec, recurrence Fundamentally, utilizing the AFIP standards to evaluate chance of reappearance, i discover significant differences among the many around three risk subgroups in this new Chile (P = We examined Os ( Fig 1 ) and you can PFS …